本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Akoya Biosciences, Inc.

1.25
+0.03002.46%
盤後1.19-0.0600-4.80%17:44 EDT
成交量:10.46萬
成交額:12.81萬
市值:6,227.04萬
市盈率:-1.12
高:1.33
開:1.21
低:1.19
收:1.22
資料載入中...
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/09/06

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/07/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/06

重要事件披露

Form 8-K - Current report